Thrombospondin-1 Gene Expression Affects Survival and Tumor Spectrum of p53-Deficient Mice
- 1 November 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (5) , 1949-1956
- https://doi.org/10.1016/s0002-9440(10)63042-8
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA17007, CA64239)
- National Cancer Institute (CA17007, CA64239)
- National Heart, Lung, and Blood Institute (CA17007, CA64239)
This publication has 69 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formationThe EMBO Journal, 1998
- Tumour suppressor genes and angiogenesis: the role of TP53 in fibroblastsEuropean Journal Of Cancer, 1996
- Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic modelsEuropean Journal Of Cancer, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progressionBreast Cancer Research and Treatment, 1995
- Identification of Possible Inhibitory Reactive Centers in Thrombospondin 1 That May Bind Cathepsin G and Neutrophil ElastaseBiochemistry, 1994
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994
- Colocalization of thrombospondin and syndecan during murine developmentDevelopmental Dynamics, 1992
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989